Seeking Alpha

  bluebird bio, Inc. - NASDAQ

10/31/2014, 1:47 PM ET
  • May Tepper | Send Message 1 Jul

    $BLUE Cowen Maintains Buy On Bluebird Following The Acquisition Of Pregenen
    Reply (1)
    • Thomas Garrity | Send Message 1 Jul
      : What is Cowen's PPS Target?
      BLUE vs. ETF Alternatives
      Company Description
      bluebird bio Inc is a clinical-stage biotechnology focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy products. Its products portfolio consists of Lenti-D; LentiGlobin; and SCD.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States